Literature DB >> 11683412

A Drosophila model of HIV-Tat-related pathogenicity.

P A Battaglia1, S Zito, A Macchini, F Gigliani.   

Abstract

To analyze the mechanism of Tat-mediated HIV pathogenicity, we produced a Drosophila melanogaster strain transgenic for HIV-tat gene and induced the expression of the protein during Drosophila development. By in vitro and in vivo experiments, we demonstrated that Tat specifically binds to tubulin via the MAP-binding domain of tubulin, and that this interaction delays the polymerization of tubulin and induces a premature stop to microtubule-dependent cytoplasmic streaming. The delay in the polymerization of microtubules, the tracks for the transport of the axes determinants, alters the positioning of the dorso-ventral axis as shown by the mislocalization of Gurken and Kinesin in oocyte of Drosophila after Tat induction. These results validate the use of Drosophila as a tool to study the molecular mechanism of viral gene products and suggest that Tat-tubulin interaction is responsible for neurodegenerative diseases associated with AIDS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11683412     DOI: 10.1242/jcs.114.15.2787

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  15 in total

Review 1.  Genetic variation and function of the HIV-1 Tat protein.

Authors:  Cassandra Spector; Anthony R Mele; Brian Wigdahl; Michael R Nonnemacher
Journal:  Med Microbiol Immunol       Date:  2019-03-05       Impact factor: 3.402

2.  Neurodegenerative effects of recombinant HIV-1 Tat(1-86) are associated with inhibition of microtubule formation and oxidative stress-related reductions in microtubule-associated protein-2(a,b).

Authors:  Tracy R Butler; Katherine J Smith; Rachel L Self; Brittany B Braden; Mark A Prendergast
Journal:  Neurochem Res       Date:  2011-01-23       Impact factor: 3.996

3.  Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon.

Authors:  M R López-Huertas; S Callejas; D Abia; E Mateos; A Dopazo; J Alcamí; M Coiras
Journal:  Nucleic Acids Res       Date:  2010-02-05       Impact factor: 16.971

4.  Human cytomegalovirus immediate-early-gene expression disrupts embryogenesis in transgenic Drosophila.

Authors:  Racheli Steinberg; Yonat Shemer-Avni; Noa Adler; Shira Neuman-Silberberg
Journal:  Transgenic Res       Date:  2007-10-03       Impact factor: 2.788

5.  Characterization of gene expression regulated by human OTK18 using Drosophila melanogaster as a model system for innate immunity.

Authors:  Cole R Spresser; Sarah E Marshall; Kimberly A Carlson
Journal:  J Genet       Date:  2008-08       Impact factor: 1.166

6.  Functional analysis of SARS-CoV-2 proteins in Drosophila identifies Orf6-induced pathogenic effects with Selinexor as an effective treatment.

Authors:  Jun-Yi Zhu; Jin-Gu Lee; Joyce van de Leemput; Hangnoh Lee; Zhe Han
Journal:  Cell Biosci       Date:  2021-03-25       Impact factor: 7.133

7.  The Drosophila melanogaster host model.

Authors:  Christina O Igboin; Ann L Griffen; Eugene J Leys
Journal:  J Oral Microbiol       Date:  2012-02-21       Impact factor: 5.474

Review 8.  Drosophila as a genetic model for studying pathogenic human viruses.

Authors:  Tamara T Hughes; Amanda L Allen; Joseph E Bardin; Megan N Christian; Kansei Daimon; Kelsey D Dozier; Caom L Hansen; Lisa M Holcomb; Joseph Ahlander
Journal:  Virology       Date:  2011-12-15       Impact factor: 3.616

9.  The HIV-1 Vpu protein induces apoptosis in Drosophila via activation of JNK signaling.

Authors:  Christelle Marchal; Gérald Vinatier; Matthieu Sanial; Anne Plessis; Anne-Marie Pret; Bernadette Limbourg-Bouchon; Laurent Théodore; Sophie Netter
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

Review 10.  Drosophila as a Model for Infectious Diseases.

Authors:  J Michael Harnish; Nichole Link; Shinya Yamamoto
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.